Extended cyclosporine delivery by silicone-hydrogel contact lenses

Journal of Controlled Release

Volumn 154, Issue 3, 2011, Pages 267-274

  Peng, Cheng Chun ^a   Chauhan, Anuj ^a  

^a University of Florida   (United States)

Author keywords

Cyclosporine A; Dry eye; Ophthalmic drug delivery; Silicone contact lens; Vitamin E

Indexed keywords

CYCLOSPORINE A; DRY EYE; EXTENDED WEARS; EYE DROPS; OIL-IN-WATER EMULSIONS; OPHTHALMIC DRUG DELIVERY; PARTITION COEFFICIENT; PILOT STUDIES; RELEASE PROFILES; RESIDENCE TIME; SILICONE HYDROGELS; VITAMIN E;

BIOCHEMISTRY; CONTROLLED DRUG DELIVERY; EMULSIFICATION; EMULSIONS; HYDROGELS; SILICONES;

CONTACT LENSES;

ALPHA TOCOPHEROL; CYCLOSPORIN A; SILICONE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; HYDROGEL; PARTITION COEFFICIENT; PILOT STUDY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

CONTACT LENSES; CYCLOSPORINE; DELAYED-ACTION PREPARATIONS; DERMATOLOGIC AGENTS; HYDROGEL; REFRACTOMETRY; SILICONES; VITAMIN E;

EID: 80052534766     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.06.028     Document Type: Article

References (45)

1. M. Calonge The treatment of dry eye Surv. Ophthalmol. 45 2001 S227 S239
2. R.C. Walton, R.B. Nussenblatt, and S.M. Whitcup Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents Ophthalmology 105 11 1998 2028 2034 (Pubitemid 30211769)
3. P. Kulkarni Review: Uveitis and immunosuppressive drugs J. Ocul. Pharmacol. Ther. 17 2 2001 181 187 (Pubitemid 32299082)
4. N. Pucci, E. Novembre, A. Cianferoni, E. Lombardi, R. Bernardini, R. Caputo, L. Campa, and A. Vierucci Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis Ann. Allergy Asthma Immunol. 89 3 2002 298 303
5. D.M. Wilson, G.R. John, and J.P. Callen Peripheral ulcerative keratitis - an extracutaneous neutrophilic disorder: Report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy J. Am. Acad. Dermatol. 40 2 1999 331 334 (Pubitemid 29076093)
6. J.C. Hill The use of cyclosporine in high-risk keratoplasty Am. J. Ophthalmol. 107 5 1989 506 510 (Pubitemid 19136623)
7. G. Ismailos, C. Reppas, J.B. Dressman, and P. Macheras Unusual solubility behavior of cyclosporine-A in aqueous-media J. Pharm. Pharmacol. 43 4 1991 287 289
8. http://www.accessdata.fda.gov/drugsatfda-docs/nda/2003/21-023-Restasis. cfm
9. D. Fonn Targeting contact lens induced dryness and discomfort: What properties will make lenses more comfortable Optom. Vis. Sci. 84 4 2007 279 285 (Pubitemid 46624852)
10. J.L. Davis, B.C. Gilger, and M.R. Robinson Novel approaches to ocular drug delivery Curr. Opin. Mol. Ther. 6 2 2004 195 205
11. M.R. Robinson, K.G. Csaky, R.B. Nussenblatt, J.A. Smith, P. Yuan, C. Sung, M.P. Fronheiser, H. Kim, Ocular therapeutic agent delivery devices and methods for making and using such devices, US Patent 7658364 B2.
12. H. Kim, K.G. Csaky, B.C. Gilger, J.P. Dunn, S.S. Lee, M. Tremblay, F. de Monasterio, G. Tansey, P. Yuan, P.M. Bungay, R.J. Lutz, and M.R. Robinson Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease Investig. Ophthalmol. Vis. Sci. 46 2 2005 655 662 (Pubitemid 40270349)
13. B.C. Gilger, J.H. Salmon, D.A. Wilkie, L.P.J. Cruysberg, J. Kim, M. Hayat, H. Kim, S. Kim, P. Yuan, S.S. Lee, S.M. Harrington, P.R. Murray, H.F. Edelhauser, K.G. Csaky, and M.R. Robinson A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis Investig. Ophthalmol. Vis. Sci. 47 6 2006 2596 2605 (Pubitemid 351639847)
14. S.S. Lee, H. Kim, N.S. Wang, P.M. Bungay, B.C. Gilger, P. Yuan, J. Kim, K.G. Csaky, and M.R. Robinson A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection Investig. Ophthalmol. Vis. Sci. 48 5 2007 2023 2029 (Pubitemid 351261270)
15. M.R. Robinson, S.S. Lee, B.I. Rubin, A.S. Wayne, S.Z. Pavletic, M.R. Bishop, R. Childs, A.J. Barrett, and K.G. Csaky Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease Bone Marrow Transplant. 33 10 2004 1031 1035 (Pubitemid 38744790)
16. D. Benezra, and G. Maftzir Ocular penetration of cyclosporine-A in the rat eye Arch. Ophthalmol. 108 4 1990 584 587 (Pubitemid 20142544)
17. M.J. Doughty, D. Fonn, D. Richter, T. Simpson, B. Caffery, and K. Gordon A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada Optometry Vis. Sci. 74 8 1997 624 631 (Pubitemid 27432771)
18. C.G. Begley, R.L. Chalmers, G.L. Mitchell, K.K. Nichols, B. Caffery, T. Simpson, R. DuToit, J. Portello, and L. Davis Characterization of ocular surface symptoms from optometric practices in North America Cornea 20 6 2001 610 618 (Pubitemid 32706197)
19. C. Gupta, and A. Chauhan Ophthalmic delivery of cyclosporine A by punctal plugs J. Control. Release 150 1 2011 70 76
20. N.A. McNamara, K.A. Polse, R.J. Brand, A.D. Graham, J.S. Chan, and C.D. McKenney Tear mixing under a soft contact lens: Effects of lens diameter Am. J. Ophthalmol. 127 6 1999 659 665 (Pubitemid 29266741)
21. J.L. Creech, A. Chauhan, and C.J. Radke Dispersive mixing in the posterior tear film under a soft contact lens Ind. Eng. Chem. Res. 40 14 2001 3015 3026 (Pubitemid 33015298)
22. C.C. Li, and A. Chauhan Modeling ophthalmic drug delivery by soaked contact lenses Ind. Eng. Chem. Res. 45 10 2006 3718 3734 (Pubitemid 43812810)
23. D. Gulsen, and A. Chauhan Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle Int. J. Pharm. 292 1-2 2005 95 117 (Pubitemid 40255792)
24. D. Gulsen, C.C. Li, and A. Chauhan Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery Curr. Eye Res. 30 12 2005 1071 1080 (Pubitemid 41798067)
25. Y. Kapoor, and A. Chauhan Drug and surfactant transport in Cyclosporine A and Brij 98 laden p-HEMA hydrogels J. Colloid Interface Sci. 322 2 2008 624 633
26. Y. Kapoor, and A. Chauhan Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels Int. J. Pharm. 361 1-2 2008 222 229
27. Y. Kapoor, J.C. Thomas, G. Tan, V.T. John, and A. Chauhan Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs Biomaterials 30 5 2009 867 878
28. M. Ali, S. Horikawa, S. Venkatesh, J. Saha, J.W. Hong, and M.E. Byrne Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow J. Control. Release 124 3 2007 154 162 (Pubitemid 350110488)
29. M.E. Byrne, K. Park, and N.A. Peppas Molecular imprinting within hydrogels Adv. Drug Deliv. Rev. 54 1 2002 149 161 (Pubitemid 34075318)
30. S. Venkatesh, S.P. Sizemore, and M.E. Byrne Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics Biomaterials 28 4 2007 717 724 (Pubitemid 44754878)
31. C. Alvarez-Lorenzo, H. Hiratani, J.L. Gomez-Amoza, R. Martinez-Pacheco, C. Souto, and A. Concheiro Soft contact lenses capable of sustained delivery of timolol J. Pharm. Sci. 91 10 2002 2182 2192
32. H. Hiratani, and C. Alvarez-Lorenzo Timolol uptake and release by imprinted soft contact lenses made of N, N-diethylacrylamide and methacrylic acid J. Control. Release 83 2 2002 223 230 (Pubitemid 35279467)
33. H. Hiratani, and C. Alvarez-Lorenzo The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems Biomaterials 25 6 2004 1105 1113 (Pubitemid 37393300)
34. H. Hiratani, A. Fujiwara, Y. Tamiya, Y. Mizutani, and C. Alvarez-Lorenzo Ocular release of timolol from molecularly imprinted soft contact lenses Biomaterials 26 11 2005 1293 1298 (Pubitemid 39314503)
35. H. Hiratani, Y. Mizutani, and C. Alvarez-Lorenzo Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities Macromol. Biosci. 5 8 2005 728 733 (Pubitemid 41232823)
36. J.B. Ciolino, T.R. Hoare, N.G. Iwata, I. Behlau, C.H. Dohlman, R. Langer, and D.S. Kohane A drug-eluting contact lens Investig. Ophthalmol. Vis. Sci. 50 7 2009 3346 3352
37. C.C.S. Karlgard, N.S. Wong, L.W. Jones, and C. Moresoli In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials Int. J. Pharm. 257 1-2 2003 141 151 (Pubitemid 36507040)
38. J. Kim, A. Conway, and A. Chauhan Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses Biomaterials 29 14 2008 2259 2269
39. J. Kim, C.C. Peng, and A. Chauhan Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitmain E J. Control. Release 148 2010 110 116
40. C.C. Peng, J. Kim, and A. Chauhan Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing Vitamin E diffusion barriers Biomaterials 31 14 2010 4032 4047
41. M.M. Hom Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients Eye Contact Lens 32 2 2006 109 111 (Pubitemid 44510058)
42. C. Gupta, and A. Chauhan Drug transport in HEMA conjunctival inserts containing precipitated drug particles J. Colloid Interface Sci. 347 1 2010 31 42
43. http://www.allergan.com/assets/pdf/restasis-pi.pdf
44. K. Sall, O.D. Stevenson, T.K. Mundorf, B.L. Reis, and A.P.S.G. Cs Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease Ophthalmology 107 4 2000 631 639 (Pubitemid 30191329)
45. D. Stevenson, J. Tauber, B.L. Reis, and A.P.S.G. Cyclosporin Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease - A dose-ranging, randomized trial Ophthalmology 107 5 2000 967 974